ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples. (Q54416271)

29 May 2018

title

ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples. (English)

1 reference

29 May 2018

1 reference

Yohei Miyagi

1

1 reference

29 May 2018

Takeshi Sasaki

2

1 reference

29 May 2018

Kiyoshi Fujinami

3

1 reference

29 May 2018

Jinyu Sano

4

1 reference

29 May 2018

Yutaka Senga

5

1 reference

29 May 2018

Takeshi Miura

6

1 reference

29 May 2018

Yoichi Kameda

7

1 reference

29 May 2018

Yuji Sakuma

8

1 reference

29 May 2018

Yoshiyasu Nakamura

9

1 reference

29 May 2018

Masaoki Harada

10

1 reference

29 May 2018

Eiju Tsuchiya

11

1 reference

29 May 2018

publication date

6 August 2010

1 reference

29 May 2018

published in

Modern Pathology

1 reference

29 May 2018

volume

23

1 reference

29 May 2018

issue

11

1 reference

29 May 2018

page(s)

1492-1498

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.149

exact match

0 references

cites work

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Recurrent gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Lung cancer in never smokers--a different disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Transcriptome sequencing to detect gene fusions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Molecular analysis of multifocal prostate cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

Genome-Wide Linkage Analysis of TMPRSS2-ERG Fusion in Familial Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.149

10.1038/MODPATHOL.2010.149

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

20693979

1 reference

29 May 2018